Broken redirects
Jump to navigation
Jump to search
The following redirects link to non-existent pages:
Showing below up to 17 results in range #2,331 to #2,347.
- FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study → Special:Badtitle/NS100:FFR-guided PCI Reduces Incidence of Clinical Events in Patients with Multi-Vessel Disease: Results of the FAME Study
- Facilitated PCI: No Benefit in FINESSE → Special:Badtitle/NS100:Facilitated PCI: No Benefit in FINESSE
- Feedback regulation of catecholamines levels through an enzyme called renalase → Special:Badtitle/NS100:Feedback regulation of catecholamines levels through an enzyme called renalase
- Fibrinolysis Followed by PCI Yielded Similar 1-Year Survival Rates to Primary PCI for STEMI in the French Registry → Special:Badtitle/NS100:Fibrinolysis Followed by PCI Yielded Similar 1-Year Survival Rates to Primary PCI for STEMI in the French Registry
- Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial → Special:Badtitle/NS100:Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial
- Function of an obesity-associated gene defined → Special:Badtitle/NS100:Function of an obesity-associated gene defined
- IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes → Special:Badtitle/NS100:IMAGINE reported: early ACE inhibitor therapy in low risk CABG patients associated with worse early outcomes
- New data on possible pro-thrombotic effects of pioglitazone → Special:Badtitle/NS100:New data on possible pro-thrombotic effects of pioglitazone
- Special:Badtitle/NS100:No Connection Between Vaccines & Autism, Original Data Faked in Lancet → Special:Badtitle/NS100:No Connection Between Vaccines & Autism, Original Data Faked in ''Lancet''
- No cardiovascular risk associated with coffee consumption after MI → Special:Badtitle/NS100:No cardiovascular risk associated with coffee consumption after MI
- Optimal does of aspirin following ST-elevation myocardial infarction → Special:Badtitle/NS100:Optimal does of aspirin following ST-elevation myocardial infarction
- PCI not Cost Effective in the Occluded Artery Trial (OAT) → Special:Badtitle/NS100:PCI not Cost Effective in the Occluded Artery Trial (OAT)
- RACE study: Statewide System for Coronary Reperfusion for STEMI Patients Can Improve Quality of Care → Special:Badtitle/NS100:RACE study: Statewide System for Coronary Reperfusion for STEMI Patients Can Improve Quality of Care
- STEMI patients: the untreated, reperfusion eligible. August 8, 2007 → Special:Badtitle/NS100:STEMI patients: the untreated, reperfusion eligible.
- Today in Medicine: Study on the Effect of Obesity on Mortality Rates Following MI → Special:Badtitle/NS100:Study on the Effect of Obesity on Mortality Rates Following MI
- The ARMYDA 4 Trial → Special:Badtitle/NS100:The ARMYDA 4 Trial
- Unstable Angina (UA) and Non-ST-Elevation Myocardial Infarction (NSTEMI) ACC/AHA Guidelines Updated: August 7, 2007 → Special:Badtitle/NS100:Unstable Angina (UA) and Non-ST-Elevation Myocardial Infarction (NSTEMI) ACC/AHA Guidelines Updated